Canada Considers Joining FDA-EMA Complex Generic Advice Scheme, But Is It Working?
FDA And EMA Share Their Thoughts On PSA Pilot Progress So Far
Health Canada is open to the collaborative effort but is still in “preliminary discussions,” while the FDA and EMA try to attract more applicants to the parallel scientific advice pilot scheme for complex generics.
